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Abstract 
Copper chemistry has been capitalized on in a wide spectrum of biological events. The 
central importance of copper in biology lies in the diverse chemical reactivity of the redox-
active transition metal ranging from electron transfer, small molecule binding and activation, 
to catalysis. In addition to its many different roles in natural biological systems, the diverse 
chemical reactivity of copper also represents a rich opportunity and resource to develop 
synthetic bioanalytical tools for the study of biologically important species and molecules. In 
this mini-review, fluorescent probes featuring a specific copper-based chemical reaction to 
selectively detect a biologically relevant analyte will be discussed. In particular, fluorescent 
probes for sensing labile copper ions, amino acids and small reactive species will be 
highlighted. The chemical principles, advantages and limitations of the different types of 
copper-mediated chemical reactions in these fluorescent probes will be emphasized. 
 
Introduction 
Copper is an essential trace element to living organisms [1, 2]. Largely in the form of copper-
containing enzymes and proteins, the transition metal is important in many biological 
functions including oxygen transport, respiration, electron transfer, small molecule activation, 
substrate oxidation, and signal transduction. Under physiological conditions, the redox-active 
transition metal is mainly in its cuprous Cu(I) and cupric Cu(II) states which can coordinate to 
a range of nitrogen- and sulfur-based ligands. It is perhaps the unique combination of its 
redox potency, Lewis acidity and coordination properties that renders copper of central 
importance in biology. On the other hand, the same diverse chemical reactivity of copper 
also represents a great opportunity for chemists to devise new synthetic chemical tools to 
study and better understand how different chemical species play their roles in complex 
biological systems. 
Molecular imaging using analyte-responsive fluorescent probes to visualize biological 
processes at the molecular level has recently emerged as a highly efficient tool for the study 
of metal ions, reactive species and biomolecules in live biological samples [3, 4]. Two 
approaches, binding-based and reaction-based (Figure 1), are commonly used in the 
development of these luminescent probes [3, 5, 6]. In the binding-based approach, emission 
properties of the probe change upon a reversible, non-covalent binding of the target to result 
in an optical signal. Selectivity of the probe is achieved by the host-guest complementarity 
between the recognition unit of the probe and the analyte of interest. Designing a selective 
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host for recognition is not trivial, especially when the target analyte shares similar size, 
shape, surface potential or functional groups for non-covalent interactions with other 
competitive biomolecules. In the reaction-based approach, the optical readout is a result of a 
chemical transformation of the probe by the target. Specificity of the chemical reaction 
determines the selectivity of the fluorescent probe. In this mini-review, we will discuss 
several different strategies that exploit the unique and diverse chemical reactivity of copper 
for developing analyte-selective fluorescent probes for biologically important ions and 
molecules. The chemical basis in the design and working principle of these luminescent 
probes will be highlighted to demonstrate how the diverse chemical properties of copper can 
be exploited in the development of these useful bioanalytical reagents. 
 
 
Figure 1. Schematic representation of (a) binding-based and (b) reaction-based approaches 
to analyte-selective fluorescent probes. A reversible binding or a chemical transformation 
changes the emission properties of the probe to result in an optical signal. 
 
1. Luminescent Probes for Labile Copper 
In addition to the non-exchangeable copper coordinated tightly in protein active sites, the 
intracellular labile copper pool which can undergo dynamic ligand exchange has attracted 
much recent attention [7]. The redox activity of the labile copper has been associated with 
the generation of reactive oxygen species (ROS), cellular redox balance and immune 
response. Recent studies also reveal the possible involvement of labile copper in neuronal 
activity [8, 9] and signaling glucose metabolism [10, 11]. For example, a recent study has 
demonstrated that copper can modulate cyclic adenosine monophosphate signaling and 
regulate lipolysis through inhibition of the phosphodiesterase PDE3B [12]. To aid in studying 
the roles of labile copper in these physiological processes, various copper-selective 
luminescent probes that can provide direct spatiotemporal information on the transition metal 
in living cells and/or animals have been developed. The development of synthetic 
luminescent probes for the study and biological imaging of copper has been reviewed in 
detail in several articles [5, 13, 14]. In this section, different types of chemical reactions and 
strategies used in selective copper sensing are discussed. In particular, exploitation of the 
chemical properties of Cu(I) and Cu(II) for the development of copper probes specific for 
these oxidation states are highlighted. 
Due to the reducing environment in eukaryotic cells, the majority of intracellular labile copper 
exists as Cu(I). Copper sensors for cell imaging are therefore designed to target specifically 
Cu(I) over Cu(II), in addition to the selectivity against other common transition metals. Both 
binding-based and reaction-based approaches have been exploited to develop luminescent 
probes for the selective detection of Cu(I) in biological samples. On the other hand, Cu(II) is 
more dominant in the extracellular environment and has been implicated in a number of 
neurodegenerative diseases such as Alzheimer’s disease [15, 16]. As the open-shell Cu(II) 
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is a potent fluorescence quencher, most of the reported turn-on Cu(II) probes are reaction-
based. 
 
Binding-based Cu(I) probes. A large number of binding-based luminescent sensors for Cu(I) 
have been developed using the selective binding of Cu(I) to multidentate thioether ligands. 
Considering the Hard-Soft-Acid-Base principle, the soft Cu(I) can be easily discriminated by 
the soft sulfur donors from other common biogenic main group (e.g. Na+, K+, Mg2+ and Ca2+) 
and transition metals (e.g. Fe2+, Fe3+, and Zn2+) which are hard to borderline Lewis acids. 
Further Cu(I) selectivity over other soft metal ions (e.g. Hg2+ and Pb2+) may be achieved by a 
judicious choice in the size, geometry and donor number of the ligands. Fluorescent Cu(I) 
probes were obtained by coupling these thioether ligands with a fluorescent reporter whose 
emission properties can be modulated upon Cu(I)-coordination through photo-induced 
electron transfer, internal charge transfer or other mechanisms [14]. CTAP (copper-
responsive triarylpyrazoline) reported by Fahrni and co-workers, and the CS (copper 
sensor) series from the Chang group are representative examples of Cu(I) selective 
fluorescent probes. Upon coordination of Cu(I) by the aminothioether ligand in these probes, 
photo-induced electron transfer from the amine lone-pair electron is quenched, thus 
restoring emission from the fluorophore. Labile Cu(I) in the biological samples is detected by 
a fluorescence turn-on response. With the pyrazoline-based CTAP-1 and the more 
hydrophilic CTAP-2 (Figures 2a and 2b), Farhni and co-workers revealed copper localization 
in the mitochondria and Golgi in NIH 3T3 cells and demonstrated the in-gel detection of 
protein-bound copper in Atox1 (Antioxidant Protein 1) [17, 18]. Using the BODIPY 
(borondipyrromethene)-based CS1 and CS3 (Figures 2c and 2d), Chang and co-workers 
observed an increase in intracellular copper in live human embryonic kidney (HEK) cells 
upon copper enrichment and a calcium-dependent redistribution of labile copper in neurons 
respectively [19, 20]. Since then, a whole series of copper probes has been developed 
following a similar Cu(I) binding strategy with individual probes displaying various 
photophysical and organelle labeling properties [7, 21–29]. For example, the ratiometric 
copper sensor RCS1 can visualize the ascorbate-induced release of endogenous Cu(I) in 
HEK293T and C6 rat glioma cells through a ratiometric response (Figure 2e) [21]. The 
mitochondria-targeting copper sensor, Mito-CS1, has been applied to study the level of 
mitochondrial copper in fibroblasts from patients with mutations in the proteins SCO1 and 
SCO2 (synthesis of cytochrome c oxidase) (Figure 2f) [23]. Two rhodol-based copper 
probes, having improved hydrophilicity, have been used to image the labile copper pool in 
neurons to demonstrate the role of the metal in modulating neural circuit activity (Figure 2g) 
[25]. In addition to live cell imaging, by changing the imaging modality on these Cu(I) probes, 
copper can also be imaged in tissues and live animals. Using a near-IR cyanine fluorophore, 
Chang and co-workers have developed a copper probe for the in vivo imaging of copper in a 
murine Wilson disease model in transgenic mice (Figure 2h) [26]. A two-photon copper 
fluorescent probe reported by Cho and co-workers has been shown to be able to detect 
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Figure 2. Examples of binding-based Cu(I) probes. 
 
Since the fluorescence response from these binding-based Cu(I) probes is a result of the 
reversible binding of Cu(I) to the probes, one advantage of such probes is that the level of 
labile copper could be monitored in a time-dependent manner to track the changes in the 
level of labile copper over time. However, the relative binding strengths and dynamic copper 
equilibrium between the thioether ligands of the probes and the bioligands constituting the 
“labile copper pool” will need careful characterization and consideration to help address the 
role of the “labile copper pool” in the biological system being studied. Currently, “labile 
copper” broadly refers to chelatable copper with no well-defined dissociation constants. With 
the different molecular structures (e.g. macrocyclic vs acyclic) and donor combinations of the 
thioether ligands, the Cu(I) probes discussed above have different Kd values ranging from 
10-14 to 10-11 M [14, 30]. With the Kd values for copper binding proteins and glutathione 
(GSH) ranging from 10-15 to 10-12 M [30], the use of these different Cu(I) probes may lead to 
a different definition of “labile copper” when applied in different cell types or biological 
systems. In addition, considering that Cu(I) can adopt coordination numbers from 2 to 4, the 
denticity of the thioether ligands in these Cu(I) probes could vary and the assumption of a 
simple copper equilibrium involving only the bioligand/protein and the probe may not always 
be true. It is possible that a ternary protein/Cu(I)/probe complex, especially for 
bioligands/proteins with a kinetically accessible copper binding site, could also give a 
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fluorescence response. Careful interpretation of the fluorescence data will be necessary to 
extract useful biological information.    
 
Reaction-based Cu(I) probes. The rich chemical activity of Cu(I) has also been exploited to 
develop Cu(I) fluorescent sensors. One example of copper-based reactions for developing 
selective copper sensors is the Cu(I)-catalyzed azide-alkyne cycloaddition. Viguier and 
Hulme have reported an alkyne-functionalized Eu(III) complex linked with an azide-
appended dansyl antenna to induce energy transfer and result in a luminescent response 
[31]. Formation of the antenna-Eu(III) complex conjugate using a biologically relevant Cu(I)-
glutathione complex was found to result in a 10-fold luminescence enhancement.  
Another example is the copper-mediated biomimetic oxidative bond cleavage in the 
fluorescein-tris(2-picolylamine) conjugates, FluTPA1 and FluTPA2, reported by Taki and co-
workers (Figure 3) [32]. In FluTPA1 and FluTPA2, the fluorescein fluorophores are alkylated 
by the TPA ligand through the phenolic oxygen to yield a non-emissive form. In the presence 
of Cu(I), metal coordination followed by O2-activation at the copper centre resulted in an 
oxidative C–O bond cleavage to release the fluorophore, which in-turn produced a 
fluorescence turn-on response to report level of labile Cu(I) in live HeLa (human cervix 
epitheloid carcinoma) cells. As the C–O bond cleavage requires a specific copper-mediated 
O2 reactivity, good Cu(I) selectivity over Cu(II) and other metal ions including Mn(II), Fe(II), 
Co(II), Ni(II) and Zn(II) is achieved. By coupling the biomimetic TPA ligand onto a 
triphenylphosphonium-appended rhodol fluorophore, Taki and co-workers have reported a 
mitochondria-targeting Cu(I) fluorescent probe to visualize mitochondrial copper in live HeLa 
cells [33]. Further extending the biomimetic strategy, Chang and co-workers have recently 
prepared a TPA-derived, copper caged luciferin, CCL-1, for the in vivo bioluminescent 
imaging of labile copper in a murine model of non-alcoholic fatty liver disease in transgenic 
mice [34]. In addition, modifying the biomimetic ligand to tune the metal-O2 reactivity in the 
oxidative bond cleavage gives Fe(II)- and Co(II)-selective fluorescent probes [35, 36]. Unlike 
the reversible binding-based probes, these reaction-based probes are irreversible and only 
provide snapshots of the copper level of the sample at a single time point. However, such 
irreversible bond cleavage can drive the copper equilibrium towards the probe and in 
principle could capture any kinetically accessible copper in the biological sample. Of course, 
the fluorescent signal observed will also be dependent on the kinetics of the 
reaction/chemical step that produces the fluorescent molecule, and such kinetic properties of 
the probe will need to be taken into consideration when designing the biological experiments 
that use the probe. The definition of “labile copper” that can be detected by these reaction-
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Figure 3. Examples of reaction-based fluorescent and bioluminescent Cu(I) probes. Upon 
binding of Cu(I) to the TPA ligand, an oxidative C–O bond cleavage reaction releases the 
active luminescent reporter. 
 
Reaction-based Cu(II) probes. A common strategy in reaction-based Cu(II) sensing is based 
on the Lewis acid-catalyzed hydrolysis of hydrazides  [37, 38], esters [39, 40], lactones [41], 
lactams [42, 43] and amides [44]. The hydrolysis of these probes to yield a fluorescence 
response is usually assisted by Cu(II), which coordinates to the carbonyl group and an 
additional donor, which may also provide metal selectivity. Czarnik and co-workers first 
reported a rhodamine hydrazide derivative which is non-emissive in its ring-closed 
spirolactam form (Figure 4a) [42]. In the presence of Cu(II) in aqueous medium, the 
colourless solution turns pink with a concomitant fluorescence enhancement due to a Cu(II)-
catalyzed hydrazide hydrolysis. Using a similar strategy, Yoon and co-workers reported a 
rhodamine hydrazone appended with a boronic acid to assist in Cu(II) binding prior to the 
hydrolysis (Figure 4b) [45]. The probe has been applied in the imaging of copper in P19 
(mice embryonic teratocarcinma) cells and zebrafish. A more recent example from Chan and 
co-workers is based on the Cu(II)-catalyzed hydrolysis of 2-picolinic ester for the ratiometic 
photoacoustic imaging of the transition metal (Figure 4c). Ability of the probe to image Cu(II) 




























Figure 4. Examples of Cu(II) fluorescent probes with a Cu(II)-assisted hydrolysis 
mechanism. 
 
Reaction-based Cu(II) probes based on copper-mediated oxidation have also been reported. 
Shiraishi and co-workers have reported a BODIPY derivative which is non-fluorescent due to 
electron transfer from the amine nitrogen to the BODIPY excited state (Figure 5a) [47]. Upon 
binding of Cu(II) to the N,O-chelating ligand, a copper-mediated oxidative dehydrogenation 
leads to the formation of a Cu(I)-Schiff base complex and results in a fluorescence 
enhancement. Lin and co-workers have reported a non-fluorescent dihydrorosamine which 
can be oxidized by Cu(II) to the fluorescent rosamine (Figure 5b) [48]. The dihydrorosamine 
oxidation is selective only to Cu(II) but not other common transition metal ions such as Fe(II), 
Fe(III), Co(II), Ni(II) and Zn(II). The probe has been applied in the imaging of intracellular 
copper in live nasopharyngeal carcinoma cells. An O2-dependent oxidative bond cleavage 
reaction mediated by Cu(II) has been utilized by Bai and co-workers to develop the Cu(II)-
selective fluorescence turn-on probe (Figure 5c) [49]. Similar to FluTPA1, the Cu(II) probe 
contains a fluorescein derivative alkylated with a tridentate NNO imine ligand. Upon 
coordination to Cu(II) by the ligand, an O2-dependent oxidative bond cleavage reaction 
releases the fluorophore which subsequently converts into its fluorescent form. The 
fluorescence response is selective to Cu(II) over other first row transition metal ions and the 






















Figure 5. Examples of reaction-based Cu(II) probes with a Cu(II)-mediated oxidation 
mechanism. 
 
Comparing the Cu(II) probes based on Cu(II)-catalyzed hydrolysis and Cu(II)-mediated 
oxidation, different strategies are employed to attain Cu(II) selectivity. For Cu(II)-catalyzed 
hydrolysis, additional ligand donors that preferentially coordinate to Cu(II) are incorporated in 
the probe to distinguish Cu(II) from other competing metal ions, which are also Lewis acidic, 
to provide metal selectivity. On the other hand, for probes based on Cu(II)-mediated 
oxidation, selectivity of the probe is dependent on the specificity of the oxidation, which in 
turn relates to the electronic properties of the metal. Although metal selectivity may be more 
easily achieved once a Cu(II)-specific oxidation reaction has been identified, probe design 
and synthesis may not be trivial because the change in the covalent structure of the probe 
after oxidation will also have to result in a change in the fluorescent properties of the probe. 
Systematic variation of the photophysical properties of the probes may also not be 
straightforward. 
 
2. Luminescent Probes for Amino Acids 
Amino acids are the fundamental building blocks of proteins and are involved in numerous 
physiological processes including cell division, immune response and signal transduction 
[50, 51]. A tight regulation on amino acid concentration is important for the normal 
functioning of the body and an imbalance in physiological amino acid concentrations can 
lead to diseases and abnormal physiological responses [52]. Many amino acids can act as 
effective ligands for metal coordination, and histidine (His), methionine (Met), cysteine (Cys), 
tyrosine (Tyr), glutamate (Glu) and aspartate (Asp) are indeed common biological ligands in 
the active sites of metalloproteins. Coordination chemistry exploiting specific interactions of 
amino acid and transition metal ion is therefore a popular strategy for developing 
luminescent probes for amino acids.  
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Owing to its fast ligand exchange kinetics (solvent exchange rate ≈ 107–109 s-1 at 25 °C) [53], 
Lewis acidity, borderline hardness, higher stability than other first row transition metals in the 
Irving-Williams series and other coordination properties, Cu(II) is one of the frequently used 
transition metal ions whose coordination with amino acids has been exploited in the design 
of amino acid probes. In particular, a considerable number of His and Cys probes based on 
Cu(II) coordination chemistry have been reported [54]. We will focus here on examples of 
these Cu(II)-based His and Cys probes and discuss the general strategy. Amino acid probes 
based on other metal ions and chemistry for their recognition and detection have been 
discussed in greater detail in other reviews [50, 55]. 
Cu(II)-based histidine probes. With the imidazole side chain having borderline Lewis acidity, 
His is a common biological ligand that is frequently found in active sites of metalloenzymes 
to coordinate with metal cofactors. The rich coordination chemistry of His towards metal ions 
offers a great opportunity for developing metal-based probes for its detection. For example, 
Qian and co-workers have reported a Cu(II) complex supported by a tetradentate 
aminopyridine ligand linked to a naphthaleneimide fluorophore, and demonstrated a His-
selective fluorescence enhancement by the Cu(II) complex (Figure 6) [56]. It is suggested 
that His acted as an additional ligand to coordinate to the Cu(II) and changed the pyridine-to-
Cu(II) ligand-to-metal charge transfer and the internal charge transfer of the 
naphthaleneimide that led to the fluorescence response. The complex ensemble has been 


























f luorescence at 537 nm quenched f luorescence at 537 nm restored  
Figure 6. A Cu(II) complex-fluorophore ensemble that gives a fluorescence turn-on 
response upon histidine coordination [56]. 
 
A closely related naphthaleneimide-based Cu(II) complex ensemble with a tetradentate 
nitrogen-based ligand has been reported by the same group as a His probe (Figure 7a) [57]. 
The complex ensemble has been shown to be selective to His against other amino acids 
including Cys, Met, Lys, Ser, Tyr, Asp and Glu. As demonstrated by HPLC analysis, the 
authors proposed that the fluorescence enhancement is due to a competitive coordination of 
His to Cu(II) that removes the paramagnetic quencher from the fluorophore. The Cu(II) 
complex ensemble has been used to detect His in live MCF-7 (human breast 
adenocarcinoma) cells and bovine serum albumin. A similar naphthaleneimide-based Cu(II) 
complex with a tetradentate aminopyridine ligand from Xu and co-workers also shows good 
selectivity to His over other amino acids, and has been applied in imaging His in both live 
HeLa cells and C. elegans (Figure 7b) [58]. On the other hand, Liang and co-workers have 
reported a peptide-based Cu(II) complex-fluorophore ensemble that shows a selective 
fluorescence turn-on by His over other amino acids (Figure 7c) [59]. A fluorescein derivative 
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and a Cu(II)-aminoquinoline complex were placed on the two ends of a peptide. The length 
of the peptide was carefully chosen to ensure fluorescence quenching of the fluorescein by 
the Cu(II) complex. Competitive Cu(II) binding by His removes the paramagnetic quencher 
and restores emission from the fluorescein. Good aqueous solubility and biocompatibility are 
provided by the peptide, and the complex ensemble has been applied in the imaging of 












































+   Cu-His complex
 
Figure 7. Examples of fluorescent His probes featuring a Cu(II) decomplexation mechansim. 
 
In the above examples, selectivity of the probes towards His against other amino acids was 
all tested with equimolar amount of His and the competing amino acids at micromolar 
concentrations. While the Cu(II) in these probes showed a preferential coordination by His of 
borderline basicity over other hard (e.g. Ala, Try, Glu and Asp) and soft (e.g. Cys and Met) 
amino acids under the tested conditions, selectivity against GSH, which can be present in 
cells at millimolar level [60] and can also show competitive binding to Cu(II), was not tested. 
Indeed, a five-coordinate [CuTpyCl2] (Tpy = 2,6-terpyridine) complex which showed 
fluorescence enhancement upon formation of a ternary complex with His, fluorescence 
response can also be observed in the presence of other competitive ligands such as Cys 
[61]. 
 
Cu(II)-based cysteine probes. Cys is another common biological ligand that is found in the 
active sites of many metalloenzymes. The soft sulfur donor preferentially binds to soft metals 
like Cu(I). The highly nucleophilic thiol also distinguishes Cys from other amino acids, and 
indeed a significant number of Cys and biothiol probes have been designed based on this 
unique chemical reactivity [62, 63]. Coordination of Cys to Cu(II) not only could displace the 
metal from the initial ligand, but could also reduce Cu(II) to Cu(I) with cysteine being oxidized 




A study from Feng and co-workers showed that 1,1’-bi-2-naphthol (BINOL) can be oxidized 
by Cu(II) and the fluorescence of the oxidized BINOL was quenched by complexing with the 
Cu(II). It was found that in the presence of Cys, fluorescence of the oxidized BINOL was 
restored, which was proposed to be due to the removal of the paramagnetic Cu(II) from the 
oxidized BINOL by the thiol containing amino acid (Figure 8a) [66]. The fluorescence 
response is selective to Cys over other amino acids including His and Met, but GSH and 
homocysteine (Hcy) can also induce a fluorescence enhancement. Using a BODIPY-based 
Schiff-base Cu(II) complex, Shao and co-workers have demonstrated a Cys-dependent 
fluorescence enhancement in aqueous buffer (Figure 8b) [67]. The Cys detection 
mechanism is also proposed to be a Cys-mediated Cu(II) displacement, and the 
fluorescence turn-on is selective to Cys and Hcy over other amino acids. Other similar Cys 















+   Cu-Cys complex
 
Figure 8. Examples of fluorescent Cys probes. 
 
Due to the favourable copper coordination by His and Cys, some of Cu(II)-based probes that 
utilized such Cu(II)-decomplexation approach may give a dual response to both the amino 
acids. For example, Leung, Chan and co-workers have reported a Cu(II)-complexed 
coumarin-based fluorescent probe that shows fluorescence enhancement to His, Cys and 
biological thiols such as Hcy and GSH (Figure 9a) [72]. The Cu(II) complex ensemble 
consists of a coumarin fluorescent reporter whose fluorescence is quenched upon Cu(II) 
coordination via an N-ethylmaleimide ligand. The probe can detect His in U87MG human 
glioblastoma cells pretreated with excess of thiol scavengers. Chattopadhyay, Das and co-
workers have reported a dansyl derivative with two bis(2-picolyl)amine pendants and its 
dinuclear Cu(II) complex that gives a dual response to both His and Cys (Figure 9b) [73]. 
Two different detection mechanisms for His and Cys are proposed, in which His coordinates 
to the Cu(II) bis(2-picolyl)amine moiety in the probe, whereas Cys demetallates Cu(II) from 
the probe to result in the observed fluorescence response. The probe has been employed in 
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the detection of Cys and His in human blood plasma and in the imaging of intracellular Cys 
























Figure 9. Examples of fluorescent probes that are responsive to both His and Cys. 
 
Another type of copper-mediated reaction for the fluorescence Cys detection involves a 
Cu(II) demetallation followed by a hydrolysis of the ligand/probe. Kim and co-workers 
reported a Cu(II) complex ensemble of an iminocoumarin as a reaction-based probe for Cys 
(Figure 10) [74]. The iminocoumarin is non-fluorescent and acts as a tridentate ligand to 
coordinate to Cu(II), which stabilizes the imine from hydrolysis. In the presence of Cys, the 
thiol coordinates to the Cu(II) and the metal is displaced from the iminocoumarin. With the 
destabilization from removal of metal coordination, the imine is then hydrolyzed to give a 
highly fluorescent aldehyde derivative and result in a fluorescence turn-on. Treatment of the 
Cu(II) complex ensemble with other biological thiols such as Hcy and GSH, but not other 
amino acids including His, can also result in a fluorescence enhancement. The 
iminocoumarin-Cu(II) ensemble has also been applied in the intracellular Cys imaging in 
HepG2 cells stimulated by selective thiol modifying agent N-ethylmaleimide. A few other Cys 
probes featuring the same Cu(II) displacement followed by imine hydrolysis with other 













Figure 10. A fluorescent Cys probe based on copper(II) displacement and hydrolysis [74]. 
 
In the above examples, both the detection mechanisms for His and Cys involve Cu(II) 
coordination and/or displacement. In most of the cases, Cys displaces Cu(II) from the probes 
to restore the quenched fluorescence, whereas His acts as an additional ligand to form a 
ternary complex or displace Cu(II) to change the photophysical properties of the probes. Of 
note, the Cu-Cys (or Cu-His) complexes from the demetallation of the probes were usually 
not well characterized. Whether the copper displacement by Cys involves a reduction from 
Cu(II) to Cu(I), which might be a mechanism that provides the observed selectivity, was not 
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studied. Nevertheless, since the detection of both amino acids involve Cu(II) coordination, it 
is perhaps not surprising to notice that some of these probes could be interfered by each 
other, and their differentiation will therefore require a highly sophisticated mechanism to 
distinguish the subtle differences in Cu(II) coordination by the two amino acids.  
 
3. Luminescent Probes for Small Reactive Species 
Reactive species such as reactive oxygen species (ROS, e.g. H2O2, O2– and •OH) [77, 78] 
and reactive nitrogen species (RNS, e.g. NO and ONOO–) [79, 80] are highly reactive, short-
lived chemical species that play important roles in both normal physiology and disease 
pathology. The chemistry and biology of small reactive species in signaling and stress 
response have been an intense research topic, and bioanalytical tools that are able to 
selectively capture, recognize and report the level of the short-lived reactive species in the 
complex biological milieu are highly sought after. In recent years, different strategies 
spanning across many areas in synthetic chemistry and biology have been exploited in the 
development of luminescent probes for the selective detection of ROS and RNS in cells, 
tissues and small animals [81, 82]. Indeed, the many possibilities in the coordination and 
chemical reactivity of various metals with different molecules/substrates offer a highly 
versatile platform for developing bioanalytical tools to interrogate the roles of these reactive 
species in biological samples. Here we will discuss examples of the use of copper 
coordination chemistry in the development of luminescent probes for these reactive species. 
Nitric oxide probes. In addition to being a well-known gaseous neurotransmitter, nitric oxide 
radical (NO) is also responsible for other important physiological responses such as 
vasodilation and immune response [83, 84]. Moreover, reaction of NO with superoxide (O2–) 
produces peroxynitrite (ONOO–) which is an RNS that contributes to intracellular nitrosative 
stress [85]. As a strong π-acceptor, NO forms stable complexes with transition metals with a 
strong back π bonding. The radical can also be readily oxidized by dioxygen or transition 
metal ions [86, 87]. In fact, fluorescent probes that can directly detect NO but not its oxidized 
products are largely metal-based using various transition metals such as iron [88], cobalt 
[89–91], copper [92, 93], ruthenium [94] and rhodium [95]. We will discuss here examples of 
selective NO probes based on copper chemistry. 
Ford and co-workers have reported a Cu(II) complex of an anthracene-appended cyclam 
derivative that showed a fluorescence response to NO (Figure 11a) [96]. The anthracene 
units in the square planar Cu(II) complex are non-emissive due to intramolecular quenching 
by the paramagnetic d9 Cu(II), but becomes luminescent upon reaction with NO. Combined 
NMR, MS, UV-Vis and electrochemical studies revealed that the restored fluorescence is a 
result of N-nitrosation of the cyclam, reduction of the paramagnetic d9 Cu(II) to the 
diamagnetic d10 Cu(I), and copper displacement from the N-nitrosated cyclam. Lippard and 
co-workers have reported a Cu(II) fluorescein-based ligand complex, CuFL, derived from 
quinolinylamino phenolate, as an NO-selective fluorescent probe (Figure 11b) [97]. CuFL 
showed an 11-fold fluorescence enhancement that is selective to NO over other reactive 
species such as HNO, NO2–, NO3–, ONOO–, H2O2, O2– and ClO–. The NO induced 
fluorescence turn-on was found to be also due to the reduction of Cu(II) to Cu(I), ligand N-
nitrosation and copper decomplexation [98]. CuFL has been employed in the cellular 
imaging of intracellular NO production in murine macrophage RAW 264.7 and human 
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neuroblastoma SK-N-SH cells that were stimulated by lipopolysaccharides, interferon IFN-γ 
or estrogen treatment [98]. Other examples of NO fluorescent probes featuring the same 
reduction-N-nitrosation-decomplexation mechanism with longer emission wavelengths 
(Figures 11c and 11d) [99, 100], cellular trappability (Figures 11e and 11f) [101, 102], and 
other photophysical and cellular properties have also been reported [103–108]. Of note, 
selectivity of these Cu(II)-based NO probes were usually studied against selected ROS and 
RNS, but not other biologically competitive Cu(II) ligands (e.g. GSH, H2S, Cys and His) 
which may also displace the Cu(II) from the probes and result in a fluorescence turn-on. 
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Figure 11. Examples of fluorescent NO probes with a Cu(II) reduction and ligand N-
nitrosation mechanism for fluorescence turn-on response. 
 
In addition to the copper reduction-ligand N-nitrosation-copper displacement mechanism, 
some other Cu(II)-based NO selective fluorescent probes may involve only Cu(II) reduction 
and/or metal displacement. For example, Lippard and co-workers have reported the Cu(II) 
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complexes of dansyl-functionalized sulfonamide ligands for NO sensing in pure aqueous 
solutions (Figure 12a) [109]. Turn-on of the dansyl fluorescence was suggested to be due to 
the reduction of Cu(II) to Cu(I) and the protonation of the sulfonamide ligands. The NO-
dependent fluorescence enhancement of a similar Cu(II) complex of a dansyl-functionalized 
ligand with a pyrazole donor, on the other hand, was shown to be due only to the reduction 
of Cu(II) to Cu(I) with no ligand N-nitrosation or metal displacement (Figure 12b) [110]. 
Costero and co-workers have reported more recently a bipyridine-functionalized BODIPY 
Cu(II) complex which showed fluorescence turn-on to NO in live cells that involves only 




























Figure 12. Examples of fluorescence turn-on NO probes with a Cu(II) reduction mechanism. 
 
Nitroxyl probes. Nitroxyl (HNO) is the one-electron reduced, protonated form of NO. Both NO 
and HNO can be easily oxidized. Being in different oxidation states, NO and HNO have 
distinct chemistry and biological effects [112, 113]. In some examples of copper-based NO 
fluorescent probes, Cu(II) reduction to Cu(I) may not be exclusive to NO but can also occur 
with other chemically similar reducing agents such as HNO [114, 115]. For example, the 
three Cu(II) complexes of the benzoresorufin-based quinolinylamino ligand were found to 
give fluorescence turn-on response for both NO and HNO (Figures 13a and 13b) [116]. 
Cu(II) reduction and ligand N-nitrosation was found to be responsible for the NO-dependent 
fluorescence enhancement, similar to those NO probes discussed above. On the other hand, 
electrochemical studies revealed that oxidation of HNO to NO by the Cu(II) complexes is 
thermodynamically feasible, with quasi-reversible reduction of the copper(II) complexes 
occurring at 10–150 mV vs Fc/Fc+ (ferrocene/ferrocenium) in acetonitrile, and that NO was 
found irreversibly reduced at -1 V vs Fc/Fc+ under similar conditions. The formation of NO 
gas upon reaction of the Cu(II) complexes with HNO has also been confirmed by mass 
spectrometry, thus explaining the HNO-induced fluorescence enhancement is also due to 
the same copper(II) reduction-ligand N-nitrosation mechanism [117]. A similar 
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napthaleneimide-based Cu(II) complex also showed dual NO and HNO induced 






























Figure 13. Examples of fluorescent NO probes that are also responsive to HNO. 
 
Despite not being exclusively selective, the dual responsiveness of these fluorescent probes 
to NO and HNO suggests that, by proper tuning of the reduction potential of the Cu(II) 
complexes, attaining HNO selectivity is possible. Indeed, by using the tripodal 
triazolyl(dipicolyl)amine ligand, Lippard and Yao have respectively reported Cu(II) 
complexes of BODIPY-triazole (CuBOT-1) (Figure 14a) [118] and coumarin-triazole 
(CuCOT-1) (Figure 14b) [119]  as HNO-selective probes for HNO imaging in living cells. 
Both CuBOT-1 and CuCOT-1 display good selectivity to HNO over NO and other RNS 
including NO3–, NO2–, ONOO– and S-nitrosocysteine, and detect intracellular HNO in HeLa or 
A375 (human malignant melanoma) cells stimulated by Angeli’s salt (Na2N2O3). The 
mechanism of HNO detection and selectivity over NO by CuBOT-1 has been studied by 
electrochemistry and computation [120]. From the cyclic voltammetry experiments, it was 
found that the reduction of Cu(II) to Cu(I) in CuBOT-1 in PBS buffer at pH 7.4 by HNO is 
thermodynamically feasible, and results from the computational studies are suggestive of a 
proton-coupled electron transfer mechanism in the oxidation of HNO to NO, with the Cu(II) 
and triazole in CuBOT-1 acting respectively as the electron and proton acceptor. On the 
other hand, electrochemical studies showed that NO oxidation by CuBOT-1 is 
thermodynamically uphill, which explains the observed HNO selectivity over NO. A major 
limitation of these HNO probes is the competitive reduction by other biological reducing 
agents, and indeed CuBOT-1 and CuCOT-1 do show fluorescence enhancement in the 
presence of cysteine and/or ascorbate. Attention will be required when these probes are to 
be applied in cells. More recently, other ligand systems which provide a suitable reduction 
potential and thus HNO selectivity have also been reported [121–123]. For example, using a 
cyclam-based ligand to tune the reaction kinetics at the Cu(II) centre, HNO probes that are 
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selective against NO, RNS, ascorbate and biological thiols (e.g. Cys and GSH) have been 


































































Figure 14. Examples of fluorescent HNO probes. 
 
Hydrogen sulfide probes. Hydrogen sulfide (H2S) is another endogenous gaseous molecule 
that is involved in biological signaling [124]. By combining the fluorescence quenching effect 
of the d9 paramagnetic Cu(II) and the high stability of copper(II) sulfide (CuS, Ksp ≈ 10–36), 
H2S fluorescence turn-on driven by CuS formation and precipitation has been a major 
strategy for the design of H2S-selective fluorescent probes [125–127].    
One early example that exploits copper(II) sulfide precipitation in H2S fluorescence sensing 
is given by Chang and co-workers. A Cu(II) complex of a dipicolylamine-appended 
fluorescein derivative was prepared as a H2S probe (Figure 15a) [128]. The fluorescence of 
the ligand-fluorophore conjugate was initially quenched by the paramagnetic d9 Cu(II), but a 
robust fluorescence turn-on was observed upon reaction with sufide ions. Formation of CuS 
precipitates upon reaction of the probe with sulfide has been confirmed by energy-dispersive 
X-ray measurement. The probe is not responsive towards other inorganic anions (e.g. 
halides, sulfates, nitrates and cyanide) and no fluorescence enhancement was observed. 
However, the selectivity has not been tested against other biological thiols such as GSH, 
which can be present in millimolar range in cells and may also interfere with the H2S 
detection through a competitive binding to the Cu(II) of the probe. To overcome the possible 
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interference by intracellular thiols, Nagano and co-worker have reported hydrogen sulfide 
imaging probe, HSip-1, featuring a cyclen ligand coordinated to a Cu(II) ion as a selective 
H2S probe (Figure 10b) [129]. The use of cyclen was to enhance the stability of the Cu(II) 
complex so as to provide a better selectivity to H2S over GSH. It was found that the use of 
other azamacrocycles such as TACN (1,4,7-triazacyclononane) and cyclam as the ligand will 
result in a reduced H2S sensitivity and/or selectivity, probably because of the subtle 
differences in the stability of the Cu(II) complexes with slightly different azamacrocyclic 
ligands [129]. HSip-1 shows fluorescence turn-on only to H2S but not biological thiols such 
as Cys, Hcy and GSH, and is also selective against other inorganic sulfur compounds, ROS 
and RNS. HSip-1 has been used to detect enzymatically produced H2S in buffer and cell 
lysate, and image intracellular H2S in live HeLa cells [130–132].  
A few others H2S probes based on the same CuS precipitation mechanism with different 
ligands and/or fluorophores of different emission colors have also been reported [133–135]. 
However, selectivity of these probes has been tested only against inorganic anions such as 
phosphates, carbonates and cyanide. Fluorescence response of these probes towards 
biological thiols (e.g. Cys and GSH) and biological reductants (e.g. NO, HNO and 
ascorbate), which could also respectively displace or reduce the Cu(II) quencher, has not 
been studied. One important issue in H2S sensing using the CuS precipitation strategy is 
that the mechanism for the fluorescence response is not exclusive to the reaction between 
H2S and Cu(II). Other reactions of the Cu(II) in the probes with other biological species, such 
as metal displacement by His and Cys or Cu(II) reduction by NO and HNO as discussed 
above, may lead to other competitive pathways that also remove the paramagnetic Cu(II) 
quencher and result in a fluorescence response. More selective and specific chemistry that 
can distinguish H2S from these chemically similar species will be required if probes of high 
selectivity are needed. For example, one other common strategy for developing selective 



















































Figure 15. Examples of fluorescent H2S probes based on a CuS precipitation mechanism. 
 
Concluding Remarks 
The diverse chemistry of copper has provided the element a central and unique importance 
in natural biological systems. Different chemical reactions mediated by copper have also 
been exploited in the development of analyte-selective luminescent probes for the 
interrogation of the roles and functions of specific ions and molecules in biological systems. 
In particular, fluorescent probes that are responsive towards labile copper, His, Cys, NO, 
HNO and H2S have been successfully developed based on Cu(I)-thiol coordination, Cu(II) 
displacement, Cu(II)-catalyzed hydrolysis, Cu(II)-mediated oxidation, Cu(I)-O2 chemistry, 
Cu(II) reduction, CuS precipitation and other copper-based reactions. In addition to 
diversifying the present probes with various cellular and photophysical properties to fit the 
needs of different experiments and expanding the scope of bioanalytes that can be detected, 
another important direction for future development will be further improving the selectivity of 
the probes and more careful verifications of the in vitro selectivity in relevant biological 
conditions, especially when the chemistry involved in the probes could be applied to other 
chemically and/or biologically similar species (e.g. Cu(II) coordination by His and Cys, Cu(II) 
reduction by NO and HNO). With creative and careful molecular designs, the rich chemistry 
of copper (and other metals) can be turned into useful molecular tools for studying the 








Atox 1: Antioxidant protein 1 
BINOL: 1,1’-bi-2-naphthol 
BODIPY: boron dipyrromethene 
CCL: copper caged luciferin 
CuBOT: Cu(II) BODIPY-triazole 
CuCOT: Cu(II) coumarin-triazole 
CuFL: Cu(II) fluorescein-based ligand 




CTAP: copper-responsive triarylpyrozoline 
Fc/Fc+: ferrocene/ferrocenium 





HPLC: high performance liquid chromatography 
HSip-1: hydrogen sulfide imaging probe-1 
IR: infrared 
Met: methionine 
Mito-CS1: mitochondria-targeting copper sensor 
NMR: nuclear magnetic resonance 
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PBS: phosphate-buffered saline 
RCS1: ratiometric copper sensor 
RNS: reactive nitrogen species 
ROS: reactive oxygen species 
Ser: serine 
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